# Pharmacokinetics of HR17031 Injection in Healthy Subjects

> **NCT05031871** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** HR17031 injection ；INS068 injection；SHR20004 injection
- **DRUG:** HR17031 injection ；INS068 injection；SHR20004 injection
- **DRUG:** HR17031 injection ；INS068 injection；SHR20004 injection
- **DRUG:** HR17031 injection ；INS068 injection；SHR20004 injection

## Key facts

- **NCT ID:** NCT05031871
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-02
- **Primary completion:** 2021-11-19
- **Final completion:** 2021-11-19
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05031871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05031871, "Pharmacokinetics of HR17031 Injection in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05031871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*